Development Of The Inactivated QazCovid-In Vaccine: Protective Efficacy Of The Vaccine In Syrian Hamsters
K. Zhugunissov, K. Zakarya, B. Khairullin, M. Orynbayev, Y. Abduraimov, M. Kassenov, K. Sultankulova, A. Kerimbayev, S. Nurabayev, B. Myrzhakhmetova, A. Nakhanov, A. Nurpeisova, O. Chervyakova, N. Assanzhanova, Y. Burashev, , L. Kutumbetov
This study develops an inactivated SARS-CoV-2 vaccine, QazCovid-in, and demonstrates its protective efficacy in Syrian hamsters by preventing viral replication and acute pneumonia.
bioRxiv · Jul 13, 2021Immunology